
浏览全部资源
扫码关注微信
河南中医药大学 第二临床医学院,郑州 450002
张芳,在读硕士,从事中医药防治男科疾病的研究, E-mail:356568584@qq.com
孙自学,硕士,主任医师,从事中医药防治男科疾病的研究, E-mail:sunhhzx@163.com
收稿日期:2020-11-25,
网络出版日期:2021-01-04,
纸质出版日期:2021-06-05
移动端阅览
张芳,孙自学,邱荃等.益肾通络方治疗少弱精子型男性不育症肾虚瘀阻证的临床疗效[J].中国实验方剂学杂志,2021,27(11):112-116.
ZHANG Fang,SUN Zi-xue,QIU Quan,et al.Clinical Efficacy on Yishen Tongluofang for Treatment of Male Infertility with Deficiency and Stasis of Kidney[J].Chinese Journal of Experimental Traditional Medical Formulae,2021,27(11):112-116.
张芳,孙自学,邱荃等.益肾通络方治疗少弱精子型男性不育症肾虚瘀阻证的临床疗效[J].中国实验方剂学杂志,2021,27(11):112-116. DOI: 10.13422/j.cnki.syfjx.20210531.
ZHANG Fang,SUN Zi-xue,QIU Quan,et al.Clinical Efficacy on Yishen Tongluofang for Treatment of Male Infertility with Deficiency and Stasis of Kidney[J].Chinese Journal of Experimental Traditional Medical Formulae,2021,27(11):112-116. DOI: 10.13422/j.cnki.syfjx.20210531.
目的
2
观察益肾通络方治疗少弱精子型男性不育症肾虚瘀阻证的临床疗效及对血清性激素和精浆微环境的影响。
方法
2
将104例患者随机按数字表法分为观察组和对照组各52例。对照组口服复方玄驹胶囊,3粒/次,3次/d。观察组内服益肾通络方,1剂/d。两组疗程均为3个月,并随访3个月。记录6个月内配偶受孕情况;进行治疗前后精液参数检查和肾虚瘀阻证评分;检测治疗前后精浆锌、精浆果糖、精浆弹性蛋白酶、精浆酸性磷酸酶,精浆
α
葡糖苷酶水平及血清促卵泡生成素(FSH),促黄体生成激素(LH),泌乳素(PRT),睾酮(T)水平。
结果
2
在6个月观察期间,观察组配偶受孕率为22.00%高于对照组的10.00%,但差异无统计学意义(
χ
2
=2.678,
P
>
0.05);观察组临床疗效优于对照组(
Z
=2.326,
P
<
0.01);观察组精子浓度、精子活率、精子活力、正常形态精子、直线运动速度均高于对照组(
P
<
0.01);观察组精浆锌、精浆果糖水平均高于对照组(
P
<
0.01),肾虚瘀阻证评分低于对照组(
P
<
0.01);观察组血清FSH,LH,PRT水平均低于对照组(
P
<
0.01),T水平高于对照组(
P
<
0.01);观察组精浆弹性蛋白酶低于对照组(
P
<
0.01),精浆酸性磷酸酶,精浆
α
葡糖苷酶水平均高于对照组(
P
<
0.01)。
结论
2
益肾通络方用于少弱精子型男性不育症肾虚瘀阻证患者可改善精子参数,调节性激素水平和精浆环境,有提高配偶受孕趋势,临床疗效值得进一步研究。
Object
2
To observe the clinical efficacy of Yishen Tongluofang in treating oligosperm type male infertility with kidney deficiency and blood stasis syndrome and explore its effect on serum sex hormones and seminal plasma microenviro.
Method
2
One hundred and four patients were randomly divided into observation group and control group with 52 cases each. Patients in control group took compound Xuanju capsules orally, 3 capsules/time, 3 times/day. Patients in observation group took Yishen Tongluofang, 1 dose/day. Treatment courses continued three months and followed up for three months in both groups. The pregnancy situations of spouses within six months were recorded. Examination of semen parameters before and after treatment and score of kidney deficiency and blood stasis syndrome were conducted. The levels of seminal plasma zinc, fructose, elastase, acid phosphatase and
α
-glucosidase, serum follicle stimulating hormone (FSH), luteinizing hormone (LH), prolactin (PRT) and testosterone (T) were detected before and after treatment.
Result
2
During the observation period of six months, the pregnancy rate of spouses in the observation group was 22.00%, higher than 10.00% in the control group, but the difference was not statistically significant (
χ
2
=2.678,
P
>
0.05). The clinical efficacy in the observation group was better than that of the control group (
Z
=2.326,
P
<
0.01). Sperm concentration, sperm motility, sperm motility, normal morphological sperm and linear movement speed of the observation group were all superior to those of the control group
(
P
<
0.01). The levels of zinc and fructose in seminal plasma of the observation group were higher than those of the control group (
P
<
0.01), and the score of kidney deficiency and blood stasis syndrome was lower than that of the control group (
P
<
0.01). Serum FSH, LH and PRT levels in the observation group were lower than those in the control group (
P
<
0.01), and the T level was higher than that in the control group (
P
<
0.01). The seminal plasma elastase of the observation group was lower than that of the control group, while the levels of acid phosphatase and
α
-glucosidase were higher than those of the control group (
P
<
0.01).
Conclusion
2
Yishen Tongluofang can significantly improve sperm parameters, regulate the level of sex hormones and seminal plasma environment in patients with oligosperm type male infertility, and improve the tendency of spouse pregnancy. Its clinical efficacy is better,so it is worthy of further research and application.
ZHOU Z , ZHENG D , WU H , et al . Epidemiology of infertility in China: a population-based study [J]. BJOG , 2018 , 125 ( 4 ): 432 - 441 .
姜辉 , 王传航 , 洪锴 , 等 . 男性不育症诊断与治疗指南 [M]. 北京 : 人民卫生出版社 , 2017 : 3 - 5 .
王哲 , 陈亿慧 , 蔡平平 . 少弱精子症中西医研究进展 [J]. 河北中医 , 2017 , 39 ( 9 ): 1434 - 1440 .
中国中西医结合学会男科专业委员会 . 男性不育症中西医结合诊疗指南(试行版) [J]. 中国中西医结合杂志 , 2015 , 35 ( 9 ): 1034 - 1038 .
张跃辉 , 许洪飞 , 孙玉华 , 等 . 当代中医对男性不育的辨证思路 [J]. 辽宁中医杂志 , 2019 , 46 ( 7 ): 1422 - 1424 .
邱荃 , 孙自学 . 特发性弱精子不育症益肾通络法探讨 [J]. 时珍国医国药 , 2020 , 31 ( 5 ): 1202 - 1204 .
张华 , 孙自学 . 益肾通络方治疗慢性前列腺炎肾虚血瘀证的临床观察 [J]. 中国实验方剂学杂志 , 2018 , 24 ( 21 ): 182 - 187 .
张华 , 孙自学 . 益肾通络方治疗肾精亏虚型男性不育症的临床研究 [J]. 中药材 , 2018 , 41 ( 7 ): 1746 - 1749 .
陈翔 , 孙自学 , 赵帅鹏 , 等 . 益肾通络方联合微创手术治疗精索静脉曲张伴弱精子症的疗效评价 [J]. 中华男科学杂志 , 2020 , 26 ( 4 ): 341 - 345 .
李勋 , 董亚洲 , 陈建设 , 等 . 显微镜下输精管附睾吻合术联合益肾通络方治疗附睾梗阻性无精子症临床观察 [J]. 光明中医 , 2020 , 35 ( 20 ): 3150 - 3153 .
世界卫生组织 . 人类精液及精液-子宫颈黏液相互作用实验室检验手册 [M]. 4 版, 北京 : 人民卫生出版社 , 2001 : 17 - 26 .
郑筱萸 . 中药新药临床研究指导原则 [M]. 第一辑 , 中华人民共和国卫生部 , 1993 : 192 - 195 .
彭媛红 . 精子代谢与男性不育的相关性研究进展 [J]. 国际生殖健康/计划生育杂志 , 2018 , 37 ( 4 ): 342 - 346 .
李艳春 . 麒麟加减方辨治男性不育肾精亏损证临床研究 [J]. 中医学报 , 2017 , 32 ( 12 ): 2448 - 2451 .
郭军华 , 何清湖 . 滋阴补肾法防治男性不育症的实验研究进展 [J]. 湖南中医药大学学报 , 2014 , 34 ( 6 ): 57 - 60 .
李宪锐 , 张耀圣 , 何军琴 , 等 .“ 从瘀论治”在男性不育症临床诊疗中的应用 [J]. 中国性科学 , 2019 , 28 ( 7 ): 129 - 131 .
郭宏志 , 刘云波 , 曾明月 , 等 . 补肾活血中药复方治疗男性免疫性不育的系统评价 [J]. 中医药导报 , 2017 , 23 ( 5 ): 99 - 102 .
柴琦琦 , 丁晶 , 卞廷松 . 复方玄驹胶囊治疗男性不育症的Meta分析 [J]. 中国性科学 , 2017 , 26 ( 10 ): 83 - 87 .
陶明进 , 曹艳 . 血清性激素指标、精浆锌与果糖检测诊断男性不育症的应用价值 [J]. 中国妇幼保健 , 2019 , 34 ( 9 ): 2090 - 2092 .
郑慧澜 , 袁启龙 , 何君伟 , 等 . 不育男性精浆弹性蛋白酶水平与精液主要参数及精子DNA完整性的关系分析 [J]. 热带医学杂志 , 2019 , 19 ( 2 ): 145 - 147,169 .
王阳 , 曹志强 . 精索静脉曲张患者血清性激素水平与精液质量关系研究 [J]. 中国性科学 , 2015 , 24 ( 1 ): 3 - 5
0
浏览量
19
下载量
8
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621